Magnesium sulfate effectiveness for ERAS Protocols
Author Information
- Author(s)
- Karst, Camille
- Details
-
Camille Karst, DNP(c), RN
- Sigma Affiliation
- Non-member
- Contributor Affiliation(s)
- Samford University
Visitor Statistics
Visits vs Downloads
Visitors - World Map
Top Visiting Countries
Country | Visits |
---|
Top Visiting Cities
City | Visits |
---|
Visits (last 6 months)
Downloads (last 6 months)
Popular Works for Karst, Camille by View
Title | Page Views |
---|
Popular Works for Karst, Camille by Download
Title | Downloads |
---|
View Citations
Citations
The citations below are meant to be used as guidelines. Patrons must make any necessary corrections before using. Pay special attention to personal names, capitalization, and dates. Always consult appropriate citation style resources for the exact formatting and punctuation guidelines.
Abstract
Magnesium sulfate has been considered a versatile anesthetic adjunct in the past, though its analgesic potential remains controversial. The discovery of its ability to block the N-methyl-D-aspartate receptor in the central nervous system has generated increasing interest in its use as a multimodal analgesic adjunct. Detrimental opioid-related side effects, as well a growing concern for opioid misuse, has heightened the desire to discover and use alternative agents for pain control. Many current Enhanced Recovery After Surgery (ERAS) protocols include intravenous (IV) magnesium sulfate as a component of the opioid-sparing anesthetic plan. In the featured case report, a 46-year-old morbidly obese female (BMI 42 kg/m2) presented for a robotic gastric sleeve for weight loss. This patient was at an increased risk for opioid-related adverse effects due to a history of obstructive sleep apnea and class III morbid obesity. As part of the facility’s ERAS protocol, the patient received celecoxib, acetaminophen, gabapentin, lidocaine, magnesium, fentanyl, ketamine, and ketorolac. Magnesium sulfate was given as a 2 g IV bolus after induction and prior to surgical incision. Throughout the maintenance phase, hemodynamic stability was maintained with 2 lactated ringers 250 mL boluses and 5 phenylephrine 100 mcg boluses for periods of hypotension. Vital signs were stable in the post-anesthesia care unit (PACU) with nonlabored spontaneous respirations and no dysrhythmias or ectopy. The patient was arousable and able to follow commands. When reassessed 45 minutes after PACU arrival, the patient was awake, alert, and resting comfortably. The patient had been weaned to room air and the SpO2 was 97%. The patient complained of occasional incisional pain with a numeric pain scale rating of 3/10 but did not request analgesics.
Acquisition Type
Proxy-submissionReview Type
None: Degree-based SubmissionRepository Posting Date
2021-03-24T17:16:05ZType
PosterFormat
Text-based DocumentLevel of Evidence
N/AResearch Approach
N/ADegree Information
Grantor | Advisor(s) | Level | Year | Samford University | Herbinger, Lisa | DNP | 2021 |
---|
Conference Information
Name | Host | Location | Ida Moffett School of Nursing DNP Poster Presentation | Samford University | Birmingham, Alabama, USA |
---|
Rights Holder
All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.
All permission requests should be directed accordingly and not to the Sigma Repository.
All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.